This pre-clinical study was performed to investigate the ability of the haemostatic fleece TachoComb ® to prevent adhesion formation following uterine surgery. Thirty rabbits were randomized to receive TachoComb ® or no intervention following incision to the right uterine horn. After 14 days, the animals were killed and examined for the presence of adhesion. The lengths of any adhesions were measured and the severity was recorded as a score (0, no adhesion; 1, adhesion easy to lyse; 2, adhesion lysed with traction; 3, adhesion separated by sharp dissection). The incidence of adhesions was 100% in the control group compared with 33% in the TachoComb ®treated animals. The mean adhesion score was significantly lower (0.7 versus 2.2) and the mean adhesion length category was significantly shorter (0.4 versus 2.0) with TachoComb ® than in the control group. This study indicates that TachoComb ® is a well-tolerated and effective means of preventing adhesion following gynaecological surgery.
Introduction
Adhesions are a common occurrence following gynaecological surgery, typically affecting around 70 -80% of cases. 1 A variety of complications may result, including pain, infertility and bowel obstruction, and re-operation may be required. Adhesion is responsible for a large number of hospitalizations and substantial financial cost. As an illustration of the scale of the cost involved, in 2004 it was estimated that the direct costs of adhesions resulting from lower abdominal surgery over a 10-year period in the UK would be over £569 million. 2 The effect on fertility is perhaps the principal issue in the gynaecological setting, as the initial surgery is often performed to treat infertility. Myomectomy, although indicated where an abnormal mass is discovered on pelvic exploration, is not recommended for infertility in the absence of a pelvic mass. This is because the procedure itself can reduce fertility, mainly due to adhesion formation. 3 When adhesion does occur, it may be treated by sharp dissection, electrocoagulation, CO 2 laser, argon laser or potassium titanyl phosphate 532 nm G Dickneite, U Rolle, D Rosenthal Adhesion prevention using haemostatic fleece in a rabbit model laser. However, adhesions re-form following adhesiolysis in as many as 97% of cases, 4 further increasing the burden on health-care resources.
TachoComb ® (Nycomed GmbH, Linz, Austria) is an equine collagen fleece coated with the fibrin sealant components fibrinogen, thrombin and aprotinin. 5, 6 It is a ready-to-use dressing employed to achieve haemostasis and tissue sealing in a variety of surgical settings. It is biodegradable, so subsequent intervention for removal of the material after healing is not required. Several studies have demonstrated that TachoComb ® is superior to standard compression for achieving suture line haemostasis following vascular reconstruction, both in terms of time to haemostasis and blood loss. 7 -9 Further studies have documented the successful use of this product in neurosurgery, renal transplantation, left ventricular free-wall rupture and resection for non-small cell lung cancer. 10 -13 The viability of TachoComb ® in the pulmonary setting is particularly noteworthy as significant stretching and contraction occur with all lung tissue.
In addition to the achievement of haemostasis, TachoComb ® may also be effective in the prevention of adhesion. 5 This study was performed to examine the efficacy of TachoComb ® in preventing adhesion following incision and suturing of the uterus in a rabbit model.
Materials and methods
This study was performed in Germany in accordance with Good Laboratory Practice and German animal welfare law. Approval was gained from the appropriate government authorities.
OPERATIVE PROCEDURE
Thirty rabbits were randomized into two equal groups: one group received post-incision TachoComb ® (supplied by ZLB Behring KK, Tokyo, Japan) and the other group served as controls. The rabbits were anaesthetized with an initial intravenous dose of 5 mg/kg ketamine hydrochloride (Ketavet ® ; Parke-Davis GmbH, Berlin, Germany) and 0.5 mg/kg xylazine hydrochloride (Rompun ® ; Bayer AG, Leverkusen, Germany), and anaesthesia was maintained with ketamine hydrochloride at 25 mg/kg per hour plus xylazine hydrochloride at 2.5 mg/kg per hour. The abdomen was opened via a midline incision to expose the uterus. A longitudinal ventral incision 2.5 cm in length was made into the right uterine horn; a scaled template was used to ensure consistency between animals. The incision was closed using continuous inverting suturing with Vicryl ® 3-0 (Ethicon, Somerville, New Jersey, USA).
For animals in the TachoComb ® group, the suture line was completely covered with a 0.8 cm × 3.0 cm piece of TachoComb ® ; in control animals, the suture line was left untreated. After 5 min of incubation, the uterus was repositioned, and the abdomen was irrigated with saline and closed using standard surgical procedures. For postoperative analgesia, 50 mg/kg intravenous metamizol sodium was given.
ASSESSMENT OF ADHESION
Fourteen days after operation, the animals were killed and the uterine horn was examined. The occurrence and severity of any adhesion of the uterine horn to the surrounding tissue was recorded using a score from 0 to 3 (0, no adhesion; 1, adhesion easy to lyse; 2, adhesion lysed with traction; 3, adhesion separated by sharp dissection).
The tissues involved and the size of each adhesion (i.e. the distance between the uterine tissue and the tissue it was adhering to) were recorded. As the exact lengths of the G Dickneite, U Rolle, D Rosenthal Adhesion prevention using haemostatic fleece in a rabbit model adhesions were difficult to determine, categories were formed. Adhesion length categories were as follows: 0 = no adhesions detectable; 0.5 = adhesions measuring ≤ 0.75 cm; 1 = adhesions measuring > 0.75 -≤ 1.25 cm; 1.5 = adhesions measuring > 1.25 -≤ 1.75 cm; 2 = adhesions measuring > 1.75 -≤ 2.25 cm; 2.5 = adhesions measuring > 2.25 -≤ 2.75 cm; 3 = adhesions measuring > 2.75 -≤ 3.25 cm; 3.5 = adhesions measuring > 3.25 -≤ 3.75 cm. Mean and SD were calculated according to the adhesion length categories.
HISTOLOGICAL ASSESSMENT
Tissue samples from around the suture line were fixed in 7% formalin and embedded in paraffin. Sections 2 -3 mm in thickness were cut, stained with haematoxylin and eosin and examined using light microscopy.
STATISTICAL ANALYSIS
The adhesion score was used as the primary efficacy parameter; the two groups were compared using Wilcoxon rank sum test. Other analyses included the occurrence of adhesion (present versus absent, using the χ 2 test) and the total length of adhesion per animal (Wilcoxon rank sum test). P-values < 0.05 were considered statistically significant.
Results
Adhesion scores were considerably lower in the TachoComb ® group compared with the controls. As shown in Fig. 1 , the median score was 0 (no adhesion) in the TachoComb ® group, compared with 2 (adhesion lysed with traction) in the control group. There was a statistically significant difference in the mean (± SD) adhesion score (0.7 ± 1.1 in the TachoComb ® group versus 2.2 ± 0.4 in the control group; P = 0.0006). Adhesion was present in all 15 animals in the control group (100%) compared with only five of the 15 animals in the TachoComb ® group (33%) (P = 0.0001).
When all the animals were included, the mean adhesion length was significantly shorter in the TachoComb ® group compared with the control group (P < 0.0001; Table 1 ). When only those animals in which adhesion occurred were considered, the mean adhesion length category remained shorter in the TachoComb ® group compared with the control group (1.2 versus 2.0). The overall appearance of the suture line in an animal with uterine adhesion is shown in Fig. 2 .
Histological investigation of the TachoComb ® -treated suture lines revealed that the outer surface of the applied TachoComb ® patch was completely covered by a new serosal layer 2 weeks after the operation (Fig. 3 ), although the TachoComb ® remained visible. The new serosal layer consisted mainly of dense connective tissue composed of collagen fibres, fibrocytes and several small blood vessels under a wellestablished layer of mesothelial cells. The TachoComb ® patch was surrounded by 
Data are number of rabbits. Some larger vessels entered the edges of the TachoComb ® patch, providing a source of white blood cells for degradation of the patch. Macrophages and epithelioid cells formed a thin cellular wall close to the equine collagen fibres. Some of these cells had multiple nucleoli and exhibited several divisional stages. The rough, fibrous structure of the equine collagen of the TachoComb ® sponge exhibited a finer, more spliced appearance than the dense collagen in the surrounding connective tissues. Between the equine collagen fibres and the muscle of the uterus, an amorphous, cystic mass containing serous fluid, fibrin matrix and remnants of the TachoComb ® coagulation components was seen. Marked degradation processes were evident within the equine collagen sponge and the haemostatic agent layer, leading to vacuole changes. Connective tissue was found close to the equine collagen sponge; this contained accumulated collagen and proliferated fibroblasts, large numbers of macrophages, and smaller numbers of plasma cells, neutrophilic granulocytes, lymphocytes and eosinophilic granulocytes. Lymphocytes and eosinophilic granulocytes were also found in local blood vessel walls. No mast cells were detected.
In one animal treated with TachoComb ® in which adhesion occurred, there was a marked increase in granulation tissue containing large quantities of plasma cells, neutrophilic granulocytes, lymphocytes and eosinophilic granulocytes adjacent to the adhesion and outside the region covered by the TachoComb ® .
The uterine muscle, submucous layer and mucosal layer all appeared unchanged. No histopathological changes or histological evidence of infection were seen.
Uterine horns not treated with TachoComb ® developed adhesions composed of dense and loose connective tissue containing variable numbers of large and small vessels.
Discussion
Adhesion formation is characterized by several distinct stages. 14 Initially, a fibrin matrix forms, generally during coagulation. Vascular granulation tissue gradually replaces the matrix; this contains macrophages, fibroblasts and giant cells. A fibrin network then becomes organized, with bundles of collagen, fibroblasts and mast cells. Next, collagen is deposited, fibroblasts become aligned, and organization advances. Finally, the adhesion matures into a fibrous band.
The adhesion formation process occurs as a consequence of the loss of normal fibrinolytic activity in the peritoneum. 15 Normal fibrinolytic activity is dependent on the function of tissue plasminogen activator; its disruption may be caused by plasminogen activator inhibitors, which are generated by pro-inflammatory cytokine stimulation of mesothelial and other cells.
A number of strategies have been investigated for adhesion prevention. Physical barriers, particularly oxidized regenerative cellulose and Gore-Tex ® (W. L. Gore Co., Flagstaff, Arizona, USA), were identified as offering some promise in a 1994 review article. 14 Two years later, a publication examining the use of Interceed (W. L. Gore Co.) and Preclude (Johnson and Johnson Medical Inc., Arlington, Texas, USA) concluded that, although barriers were the most effective method of adhesion prevention, their efficacy was limited to surgical situations in which the relevant area could be covered completely. 16 Another article reviewed the use of crystalloid or colloid solutions and chemical agents (systemic or local) as well as barriers. 17 The development of new and more effective compounds, using advances in molecular cell biology, was identified as an important need. A more recent review considered the application of hyaluronic acid, hydrogel, viscoelastic gel, vitamin E and other substances, as well as modifications of surgical technique (peritoneal non-closure, temporary abdominal oophoropexy, or changing the temperature, humidity or consistency of the gas used in laparoscopic surgery). 18 All of these articles concluded that none of the interventions available provided reliable effectiveness in the prevention of adhesion.
Fibrin sealants are routinely used in many surgical settings for the promotion of haemostasis. Typically they are used in conjunction with sutures to promote optimal wound integrity, or are used independently to seal wound sites where sutures would be inappropriate or would not be able to control bleeding. Their use for adhesion prevention has also been investigated. While a degree of efficacy has been observed, this approach does not appear to be as effective as combined hyaluronic acid and carboxymethylcellulose. 19 In the rabbit model used in this study, TachoComb ® elicited a large, significant reduction in the rate of adhesion following suturing of the uterine horn. In addition, the adhesions that did occur following TachoComb ® treatment were of reduced size and severity compared with those in the control group. These findings are consistent with previous studies of TachoComb ® . Preclinical models have shown TachoComb ® to be effective in reducing adhesion formation following surgery to the spine and after laparotomy. 20 -22 Furthermore, the ability of TachoComb ® to prevent serosal surface adhesion formation has also been demonstrated in a previous study in rabbits. 23 In the clinical setting, this product has been shown to be effective in achieving haemostasis following gynaecological surgery where methods such as sutures, ligatures, coagulation and pressure failed to prevent bleeding. 5 Data from a small number of patients also indicate that TachoComb ® may prevent adhesion formation at the application site.
Consistent with previous investigations, the results of the present study suggest that TachoComb ® does not interfere with wound healing or cause infection. Data from a larger number of animals are required to confirm this observation. In the present study, a thin serosal layer was evident on the TachoComb ® patch after 2 weeks. Similar formation of a serosal layer has been demonstrated in previous investigations of intra-abdominal adhesions. 24 In our study, the haemostatic matrix was partly replaced by collagen-rich granulation tissue at the uterine horn. Long-term histological evaluation following application of TachoComb ® to the bowel showed further degradation of the matrix over time. 24 The degradation process appears to be quicker following the application of TachoComb ® to parenchymatous organs, 25, 26 a finding that may be attributable to the dense vasculature of these tissues. In a study of TachoComb ® in patients undergoing gynaecological surgery, all but one of four patients evaluated by second-look laparoscopy (after 3 or 7 months) and all three patients evaluated by caesarean section (after 13 months, 3 years and 4 years) showed no sign of persistent TachoComb ® . 27 In addition, there was no evidence of de novo adhesion formation. 27 Such data demonstrate the natural degradation of the fleece and imply a longterm beneficial effect of TachoComb ® in preventing adhesion-induced infertility, although further long-term follow-up data are required.
TachoComb ® provides a combination of a physical barrier (collagen) with haemostatic agents (fibrinogen, thrombin and aprotinin), G Dickneite, U Rolle, D Rosenthal Adhesion prevention using haemostatic fleece in a rabbit model reducing the potential for adhesion formation by two synergistic mechanisms. The collagen fleece prevents the build-up of the initial fibrin matrix that would be necessary to bind two tissues, while the haemostatic agents encourage rapid wound healing. The TachoComb ® patch appears to induce rapid formation of unspecific fibrovascular granulation tissue. Large numbers of white blood cells accumulate at the lesion. Macrophages secrete cytokines and other mediators that attract new mesothelial cells (i.e. mesenchymal cells). 28 The mesothelial cells subsequently provide the new serosal layer that covers the TachoComb ® surface. These reparative processes clearly occur rapidly enough to prevent adhesion formation at the treated surface.
TachoComb ® is simple to apply and appears to form an effective barrier between the healing area and surrounding tissue. 6 The flexibility and durability of the product allow it to remain effective throughout the healing process and enable it to be used in situations where considerable tissue movement is anticipated. 6 In the present study, the histopathological findings demonstrated a lack of deleterious reactions to the TachoComb ® fleece and the development of normal tissue around it. This observation is in line with the comprehensive demonstration of its safety during more than 15 years of clinical use. 29, 30 The principal need for caution is in patients with known hypersensitivity to any of the components of TachoComb ® .
In conclusion, the present study indicates that TachoComb ® may be a valuable means of preventing adhesion following gynaecological surgery. Further clinical evidence, perhaps including comparisons with other adhesion-preventing approaches, is awaited with interest.
